0001209191-15-032711.txt : 20150406 0001209191-15-032711.hdr.sgml : 20150406 20150406172313 ACCESSION NUMBER: 0001209191-15-032711 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150402 FILED AS OF DATE: 20150406 DATE AS OF CHANGE: 20150406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tokai Pharmaceuticals Inc CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 Broadway STREET 2: 14TH FLOOR CITY: Cambridge STATE: MA ZIP: 02142 BUSINESS PHONE: 617-225-4348 MAIL ADDRESS: STREET 1: 1 Broadway STREET 2: 14TH FLOOR CITY: Cambridge STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kalowski Lee CENTRAL INDEX KEY: 0001618273 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 15754350 MAIL ADDRESS: STREET 1: C/O TOKAI PHARMACEUTICALS, INC. STREET 2: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-04-02 0 0001404281 Tokai Pharmaceuticals Inc TKAI 0001618273 Kalowski Lee C/O TOKAI PHARMACEUTICALS, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Common Stock 2015-04-02 4 S 0 2258 11.45 D 52346 D Shares were sold to satisfy certain tax obligations of the Reporting Person triggered by the vesting of certain restricted stock units. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.30 per share to $11.66 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents 4,567 shares of common stock held by the Reporting Person and 47,779 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. /s/ Cindy Driscoll, Attorney-in-Fact 2015-04-06